Genetic Study Launched Amid Pancreatic Concerns Over Weight Loss Medications

New Study to Explore Genetic Risks Behind Pancreatic Reactions to Weight Loss Injections British health authorities have launched an investigation into reports of pancreatic complications associated with weight loss medications such as Ozempic, Wegovy, and Mounjaro. The research, led by the Medicines and Healthcare products Regulatory Agency (MHRA) in collaboration

Read More »

Why “Nimbus” COVID Subvariant Is Spreading Fast and What to Know Now

A New Omicron Subvariant on the Rise NB.1.8.1, colloquially known as Nimbus, is an emerging sublineage of the dominant Omicron variant of SARS‑CoV‑2. First detected in Asia, Nimbus is now circulating in Europe and North America—raising concerns about a possible summer surge in Europe. Scientists note that although Nimbus is

Read More »

Childhood Vaccines Saved Millions, But Progress at Risk

A Milestone in Global Health Comes with Fresh Warnings More than 150 million childhood deaths have been prevented thanks to childhood vaccinations, according to a comprehensive global study. Since the launch of the World Health Organization’s Essential Programme on Immunization over five decades ago, more than 4.4 billion individuals have

Read More »

The Rise of Self-Managed Abortion in a Post-Roe America

A shift in how abortions happen Three years after the fall of Roe v. Wade, a growing number of women in the United States are managing their own abortions, often without stepping into a clinic. This shift is driven by expanding legal restrictions, but also by improved access to abortion

Read More »

FDA Approves Long-Acting HIV Prevention Drug Amid Access Concerns

A New Option for HIV Prevention The U.S. Food and Drug Administration has approved lenacapavir for pre-exposure prevention of HIV, a move seen as a major step in the fight against the virus. Administered twice a year, the drug offers near-complete protection, according to clinical data released last year. The

Read More »

Purdue Pharma to Pay $7.4B in New Opioid Settlement

A $7.4 billion settlement involving Purdue Pharma has received unanimous approval from all 50 U.S. states, the District of Columbia, and U.S. territories. The agreement addresses claims tied to the company’s marketing practices of opioid medications, including OxyContin. The proposed plan was filed in federal bankruptcy court in March, following

Read More »

More News

Private Credit Risks Rise

Mounting pressure in private credit markets Investor anxiety around private lending has intensified as funds that specialize in direct corporate loans face growing redemption requests. Some of the largest firms in the sector, including those managing billions of dollars in assets, have introduced limits on withdrawals to prevent sudden liquidity

Read More »

LaGuardia Crash Raises Staffing Concerns

LaGuardia Plane Crash Investigation Highlights Air Traffic Control Staffing Concerns and System Failures After Fatal Runway Collision The investigation into the fatal runway collision at LaGuardia Airport is increasingly focused on systemic challenges within air traffic control operations, particularly staffing procedures and workload distribution during overnight shifts. The crash, which

Read More »

FISA 702 Debate Targets Data Privacy Loophole

FISA Section 702 Reauthorization Sparks Debate Over Data Broker Loophole as Lawmakers Weigh Limits on Warrantless Surveillance A growing political and legal debate in Washington is intensifying ahead of the upcoming reauthorization of Section 702 of the Foreign Intelligence Surveillance Act (FISA), a key surveillance authority set to expire in

Read More »